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Annexins A1 and A2 are proteins known to function in the stress response, dampening inflammatory responses and
mediating fibrinolysis. We found, in healthy cattle recently arrived to a feedlot, that lower levels of these proteins
correlated with later development of pneumonia. Here we determine the localization of annexin A1 and A2 proteins in
the respiratory tract and in leukocytes, in healthy calves and those with Mannheimia haemolytica pneumonia. In healthy
calves, immunohistochemistry revealed cytoplasmic expression of annexin A1 in the surface epithelium of large
airways, tracheobronchial glands and goblet cells, to a lesser degree in small airways, but not in alveolar
epithelium. Immunocytochemistry labeled annexin A1 in the cytoplasm of neutrophils from blood and
bronchoalveolar lavage fluid, while minimal surface expression was detected by flow cytometry in monocytes,
macrophages and lymphocytes. Annexin A2 expression was detected in surface epithelium of small airways,
some mucosal lymphocytes, and endothelium, with weak expression in large airways, tracheobronchial glands
and alveolar septa. For both proteins, the level of expression was similar in tissues collected five days after
intrabronchial challenge with M. haemolytica compared to that from sham-inoculated calves. Annexins A1 and
A2 were both detected in leukocytes around foci of coagulative necrosis, and in necrotic cells in the center of
these foci, as well as in areas outlined above. Thus, annexins A1 and A2 are proteins produced by airway epithelial cells
that may prevent inflammation in the healthy lung and be relevant to development of pneumonia in stressed cattle.Introduction
Annexins A1 and A2 are abundant proteins in broncho-
alveolar lavage (BALF) of healthy calves, and lower levels
in healthy at-risk calves were recently found to correlate
with later development of bovine respiratory disease [1].
Annexin A1 and A2 are thought to quell inflammatory
responses, and may thus promote resolution of inflamma-
tion and limit its injurious effects. Specifically, annexin
A1 inhibits phospholipase A2 and eicosanoid synthesis,
dampens neutrophil inflammatory responses, promotes
neutrophil apoptosis, and stimulates interleukin-10 se-
cretion from macrophages [2-7]. Annexin A2 activates* Correspondence: jcaswell@uoguelph.ca
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article, unless otherwise stated.plasminogen and thereby leads to fibrinolysis, enhances
macrophage-mediated phagocytosis of apoptotic cells, and
promotes airway epithelial cell repair [8-10]. Annexin A1
and A2 expression levels vary in different tissues [11]. An
in vitro study of bovine tracheal epithelial cell cultures
showed that annexin A1 was mostly expressed in differen-
tiated cells and annexin A2 in undifferentiated cells, per-
haps reflecting the anti-inflammatory and regenerative
functions, respectively, of these proteins [12].
Annexin A1 levels increase with transportation stress
[13], consistent with in vitro findings of increased annexin
A1 and A2 expression after corticosteroid treatment of
cultured bovine tracheal epithelial cells [12]. Recently, we
found that as calves that were stressed by weaning and
transportation arrived to a feedlot, those with higher levels
of annexin A1 and A2 were less likely to later developCentral. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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the present study was to determine the localization of
annexins A1 and A2 in the respiratory tract of healthy
calves, as well as to characterize differences that occur in
inflamed lungs as a result of bacterial infection. This know-
ledge is necessary to understand how anti-inflammatory
responses develop in the lung, and for development of
methods to modulate these responses for prevention of
bovine respiratory disease.
Materials and methods
Animals and sample collection
Samples of normal respiratory tissues were collected from
two 2-month-old healthy male Holstein calves within 3 h
of euthanasia. Samples of nasal tissue, trachea, bronchi,
and lung containing alveoli and bronchioles were fixed in
formalin overnight and processed routinely.
Further samples were collected from Holstein bull
calves that were experimentally infected with M. haemo-
lytica and from sham-inoculated control calves. Proce-
dures were approved by the University of Guelph Animal
Care Committee (AUP #12R055). Six Holstein bull calves,
102–139 days of age, were randomly assigned to two groups.
M. haemolytica, isolated originally from a calf with pneu-
monia, was grown to log phase and diluted in PBS to op-
tical density of 0.74 (shown to contain 2.8 × 108 CFU/mL
as determined by follow-up colony counts). Three calves
were sedated with xylazine, and inoculated with 25 mL of
inoculum (total dose of 7 × 109 colony-forming units of
M. haemolytica in phosphate-buffered saline) using a
bronchoscope passed to the tracheal bifurcation. The 3
other calves, serving as uninfected controls, were simi-
larly inoculated with 25 mL PBS. All infected calves
developed moderately severe depression, reduced appe-
tite and fever, as well as ultrasonographic evidence of
consolidation within 2 hours of challenge that was maximal
at 24 h, and elevated serum haptoglobin levels that
peaked at 60 – 72 h after experimental challenge (data
not shown). Calves were euthanized after 5 days.
Tracheal, bronchial and lung tissues were fixed over-
night in formalin and processed routinely.
Blood and BALF cells were collected from two healthy
2-3 month old Holstein male calves for immunocyto-
chemistry. For flow cytometry, peripheral blood was col-
lected from eight healthy adult Holstein cows after their
first parturition.
Immunohistochemistry and immunocytochemistry
For immunohistochemistry (IHC), tissue sections were
prepared routinely, deparaffinized and rehydrated. Heat-
induced epitope retrieval was performed using a pressure
cooker with sodium citrate buffer (pH 6.0) at a pressure
of 18 pounds per square inch to achieve a temperature
of approximately 120 °C at full pressure (Dako NorthAmerica, California, USA). Cooled slides were washed
and treated with endogenous enzyme blocker and serum-
free protein blocker (S2003 and X0909, Dako). The slides
were incubated overnight with the primary antibody in a
humidified chamber at 4 °C, using either rabbit polyclonal
anti-human annexin A1 primary antibody (2 μg/150 μL;
H00000301-D01P, Novus Biologicals, Oakville, ON, Canada)
or goat polyclonal anti-human annexin A2 primary anti-
body (1 μg/150 μL; NB 100-881, Novus Biologicals).
Slides were then washed and incubated with secondary
antibody for 30 min, using peroxidase-based EnVision™+
Dual Link Kit (#K406511-2, Dako Cytomation, Carpinteria,
California, USA) for annexin A1, or HRP-conjugated rabbit
anti-goat immunoglobulin (1:2000, Dako Cytomation) for
annexin A2. NovaRED (Vector Laboratories, Burlingame,
California, USA) was used as chromogen with Harris
hematoxylin counterstain.
For immunocytochemistry (ICC), leukocytes were
separated from whole blood by hypotonic lysis and
cytocentrifuge preparations were made on charged slides.
Preparations of BALF leukocytes were made in the same
way. The cell preparations were fixed in acetone, and
annexin A1 was detected as described above.
As negative controls for IHC and ICC, rabbit polyclonal
anti-Toxoplasma antibody (2 μg/150 μL) was used in place
of primary antibody for annexin A1, and goat polyclonal
anti-influenza antibody (1 μg/150 μL) was similarly
used as the negative control for annexin A2. As a fur-
ther negative control, annexin A1 antibody was pre-
incubated with bovine native annexin A1 protein
(MBS318252, MybioSource, San Diego, CA, USA) for
1 h, using 1 μg antibody per 2.5 μg antigen for IHC, or
1 μg antibody per 1.5 μg antigen for 1 h for ICC. The
IHC and ICC procedures were completed as above.
Immunolabeled slides were randomized and masked so
that the assessment was done without knowledge of animal
identity or treatment group. A semi-quantitative system
was used to score each component of the respiratory sys-
tem for intensity of immunolabeling (0, no staining; 1,
equivocal; 2, minimal; 3, moderate; 4, abundant).
Flow cytometry
Leukocytes were separated from red blood cells as above
then incubated with rabbit polyclonal anti-human annexin
A1 antibody (H00000301-D01P, Novus Biologicals) at a
concentration of 0.1 mg/mL, for 2 h at 4 °C. Cells were
washed once then incubated for 15 min with sheep
anti-rabbit immunoglobulin antibody conjugated to
R-phycoerythrin (1:5 dilution, STAR35A, AbD Serotec,
Raleigh, USA) at 4 °C for 15 min. After washing, the
cells were evaluated using a BD FACScanTM (BD
Biosciences, USA) with acquisition of 300 000 events
and analyzed using FlowJo software (version 7.6, Treestar
Inc, Standord, CA) [14].
Figure 1 Immunohistochemistry for annexin A1 in normal
tissues. (A) Trachea, with intense labeling of surface epithelium and
mucosal glands. Bar = 100 μm. (B) Bronchus, with labeling of surface
epithelium including cilia and goblet cells (arrows). Bar = 70 μm.
(C) Weaker labeling of bronchiolar epithelium. Bar = 50 μm.
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The median fluorescence intensity (MFI) of leukocytes
(neutrophils, lymphocytes and monocytes) was com-
pared using Student’s t test (GraphPad, Prism 6) and
considered significant at P < 0.05.
Results
Annexin A1 and A2 expression in respiratory tissues of
healthy calves
Immunohistochemistry findings were similar in sections
of respiratory tissues from the two healthy calves (see
Additional file 1). Annexin A1 immunolabeling was
detected in the surface epithelium of the nasal cavity,
trachea, bronchi and bronchioles, in both the apical
and basal areas of the cytoplasm. The signal intensity
was highest in the epithelium lining the nasal cavity,
trachea (Figure 1A) and large bronchi (Figure 1B), lower
in small bronchi and large bronchioles (Figure 1C), and
infrequent in the terminal bronchioles. Labeling was also
detected in cilia, goblet cells, and glandular and ductular
epithelium of tracheobronchial glands (Figures 1A and B).
Alveolar macrophages and some tracheobronchial muco-
sal lymphocytes were positively labeled, but cells in the
alveolar septa were not labeled (Additional file 1F). Immu-
nolabeling was noted in the airway smooth muscle and
nerve terminals, but no labeling of connective tissue was
observed in the bronchial adventitia or the lamina propria.
Pre-incubation of annexin A1 antibody with annexin
native protein abrogated the signal intensity (Additional
file 1E). Labeling was not observed in sections treated
with the control antibody in place of the primary anti-
body (Additional file 1B).
Annexin A2 immunolabeling was detected in epithelial
cells lining the trachea, bronchi, bronchioles and alveoli,
in both apical and basal areas of the cytoplasm (Additional
file 2 and Additional file 3). The intensity of the signal was
weak in the surface epithelium of the trachea and bronchi
(Figure 2A). Bronchioles in most areas had intense
labeling that was greater than that seen in the large
airways, but this was not uniform throughout the sec-
tions (Figures 2B and D). The tracheobronchial glands
were weakly labeled, and goblet cells or cilia were not
labeled (Additional file 2A and Additional file 3A).
Large lymphocytes in the tracheobronchial lamina pro-
pria were positively labeled (Figure 2A). Although the
alveolar epithelium appeared negative, individual cells
(suggestive of macrophages and endothelial cells) in
alveolar septa were labeled (Figure 2C). Intense immu-
nolabeling was observed in the endothelium of blood
vessels (Figure 2D) and in plasma. Weak immunolabel-
ing was noted in the airway smooth muscle and nerve
terminals, and no labeling was observed in connective
tissue of the bronchial adventitia or lamina propria.
Labeling was not observed in sections treated with thenegative control antibody in place of the primary anti-
body (Additional file 2C).
Annexin A1 and A2 expression in lung following M.
haemolytica challenge
Immunohistochemical labeling of annexins A1 and A2
were compared in calves challenged with M. haemolytica
Figure 2 Immunohistochemistry for annexin A2 in normal tissues. (A) Trachea, with strong labeling of leukocytes but weak labeling of
epithelium. Bar = 30 μm. (B) Bronchiole, with prominent labeling of epithelial cells. Bar = 30 μm (C) Labeling of individual cells in an alveolar
septum consistent with macrophages or endothelial cells. (D) Absence of labeling of alveolar septa. Blood vessels (arrows) and bronchiolar
epithelium are labeled. Bar = 50 μm. Inset: Intense labeling of endothelial cells in the lamina propria of a bronchus.
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Additional file 5). The histopathologic findings included
foci of coagulative necrosis surrounded by a rim of nec-
rotic leukocytes, the presence of fibrin and neutrophils
within alveoli, and sloughed epithelial cells and infiltrationFigure 3 Immunohistochemistry for annexins A1 and A2 in calves cha
leukocytes within a focal area of coagulation necrosis (lower right) and in t
A2 expression within necrotic cells, probably leukocytes (arrows), surrounding
necrotic leukocytes bordering an area of necrosis. Bar = 25 μm. (D) In an inflam
those that have been shed from the epithelium, but exudate neutrophils areof leukocytes into the lumen of airways. The necrotic foci
and the leukocytes around the necrotic foci had patchy
areas of immunolabeling for annexin A1 and to a minor
extent for annexin A2 (Figures 3A and B). Annexin A1
labeling was intense within neutrophils at the center ofllenged with M. haemolytica. (A) Annexin A1 expression in
he band of leukocytes surrounding it. Bar = 100 μm. (B) Scant annexin
the focal area of necrosis. Bar = 50 μm. (C) Labeling of annexin A1 in
ed bronchiole, there is annexin A1 labeling of goblet cells including
unlabeled. Bar = 15 μm.
Figure 4 Immunocytochemistry for annexin A1. (A) Neutrophils
in blood labeled for annexin A1; monocytes, lymphocytes and platelets
are unlabeled. Bar = 10 μm. (B) Bronchoalveolar lavage fluid (BALF);
Annexin A1 labeling in the cytoplasm of large foamy macrophages, but
not in other macrophages. Bar = 10 μm. (C) BALF; neutrophils are rare in
normal BALF but those present are labeled for annexin A1. Bar = 10 μm.
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within bronchioles and alveoli were weakly and inconsist-
ently labeled (Figure 3D). There was shedding of goblet
cells from the bronchial epithelium and these goblet cells
were intensely labeled for annexin A1 (Figure 3D). Sub-
jectively, annexin A1 labeling of the epithelium of terminal
bronchioles was more frequently detected in M. haemoly-
tica- vs. sham-challenged animals, but this was not
confirmed by the blinded objective evaluation (Additional
file 6). Labeling for annexins A1 and A2 in the large air-
ways was not significantly different between the calves
challenged with M. haemolytica compared to the sham-
challenged calves. Use of the negative control antibody
did not result in labeling (Additional file 4C and E).
Annexin A1 expression in blood and BALF leukocytes
In normal blood leukocytes, immunocytochemistry showed
positive labeling for annexin A1 in 100% of neutrophils
(Figure 4A). The signal was detected in the cytoplasm, and
cell membrane labeling was not observed. Lymphocytes,
monocytes and platelets were not labeled. Adsorption of
the primary antibody with annexin A1 protein abrogated
the immunolabeling of the neutrophils (Additional file 7C).
In BALF, annexin A1 was not detected in most macro-
phages, nor in any lymphocytes (Additional file 7). How-
ever, annexin A1 signal was detected in low numbers
of large BAL macrophages with abundant vacuolated
cytoplasm (Figure 4B) and in large macrophages with
features suggestive of apoptosis. Neutrophils were rare
in cytocentrifuge preparations from the BALF of healthy
calves, but those neutrophils present had intense labeling
for annexin A1 (Figure 4C).
Blood leukocytes were analyzed by flow cytometry for
cell-surface expression of annexin A1 (Figure 5, Additional
file 8). Among the leukocytes, 26% of lymphocytes and
18% of monocytes had median fluorescence intensity
(MFI) above that seen in the negative control. The
difference in MFI was significant in lymphocytes and
monocytes (P < 0.0001 and P = 0.0003, Student’s t-test).
In contrast, neutrophils had little or no shift in the MFI
(P = 0.366) indicating lack of surface expression of
annexin A1.
Discussion
We investigated the distribution of annexin A1 and A2
protein within the respiratory tract of healthy cattle, and
compared this to the levels found after experimental in-
fection with M. haemolytica. In healthy calves, immunola-
beling for annexins A1 and A2 was detected throughout
the respiratory tract, especially in the airway surface
epithelium and submucosal glands. Subtle differences in
distribution and intensity of expression were noted for
these two proteins: annexin A1 labeling was greatest in
the surface and glandular epithelium of large proximalairways, and was present in goblet cells but not alveoli
or endothelium; whereas annexin A2 labeling was weak
in both surface epithelium of proximal and distal small
airways, and was more intense in leukocytes and in
endothelial cells. We found similar levels of both annex-
ins A1 and A2 in undifferentiated club cells compared
Figure 5 Flow cytometric detection of annexin A1 on the
surface of blood leukocytes. Positive: antibody against annexin A1;
negative: omission of the primary antibody. Median ± SEM from 8
animals. The MFI was significantly different from the negative control
for lymphocytes (P < 0.0001) and monocytes (P = 0.0003) but not for
neutrophils (P = 0.366).
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of the trachea and bronchi, in contrast to previous work
that was based on undifferentiated and differentiated
(secretory) cells cultured in vitro [12]. The findings
imply that the annexin A1 and A2 protein detected in
bronchoalveolar lavage fluid of healthy calves is secreted
by airway epithelial cells, since neutrophils are rare in
the lumen of normal airways. Thus, annexin A1 and A2
are among the products secreted by airway epithelial cells
that maintain an anti-inflammatory state in the healthy
respiratory tract, and regulation of these responses may
influence clinical outcome in cattle experiencing risk
factors for pneumonia.
Comparison of calves experimentally infected with
M. haemolytica and sham-inoculated calves showed
little or no difference in the localization or intensity of
immunolabeling for annexin A1 and A2. This argues
against but does not eliminate the possibility that
annexin gene expression is induced by inflammation,
since steady state levels could be achieved if protein
synthesis and secretion were both upregulated. Measur-
ing annexin A1 levels in BALF of calves with pneumo-
nia would address this possibility. However, the calves
infected with M. haemolytica showed intense labeling of
annexin A1 in leukocytes (mainly degenerating neutro-
phils) and BALF cells undergoing apoptosis. Conversely,
exudate neutrophils within the lumen of airways were
not labeled, perhaps as a result of activation-induced
secretion of this protein. These findings suggest that
during inflammation, annexin A1 released from leuko-
cytes may contribute to the amount of this protein
present in the inflamed tissue. The findings show no
change in annexin A1 immunolabeling in lung paren-
chymal cells during pneumonia, but suggest increased
levels of annexin A1 protein in the lung as a result ofleukocyte infiltration. These data are consistent with
prior detection of annexin A1 in the BALF of normal
calves and those with experimentally induced bacterial
and viral pneumonia [15,16].
The immunocytochemistry and flow cytometry results
showed annexin A1 immunolabeling in the cytoplasm of
normal blood and BALF neutrophils, but not on the cell
surface. These findings concur with findings in human
blood leukocytes [17], where annexin A1 was abundant
in the cytoplasm of neutrophils, monocytes and natural
killer cells but surface expression was not detected, and
both surface and cytoplasmic expression was low in
lymphocytes.
The flow cytometric analysis showed that, in the resting
state, only a small amount of annexin A1 was present on
the surface of lymphocytes and monocytes, and neutro-
phils had no detectable cell-surface expression of annexin
A1. In contrast, studies of human leukocytes have shown
low but detectable surface expression of annexin A1 on
neutrophils [18]. The detection of annexin A1 in the
cytoplasm of a subset of BAL macrophages does not
necessarily indicate synthesis by these cells. Instead,
annexin A1 immunolabeling in large foamy macrophages
may have resulted from pinocytosis of airway secretions
or phagocytosis of epithelial cells or neutrophils that
contained this protein.
Annexin A1 has several known anti-inflammatory
functions: it inhibits transendothelial migration and acti-
vation of neutrophils, enhances neutrophil apoptosis,
inhibits activation of MAP kinase-mediated signal trans-
duction, downregulates synthesis of inflammatory eicosa-
noids, and enhances secretion of the anti-inflammatory
cytokine interleukin-10 from macrophages [2-7]. Similarly,
the functions of annexin A2 include activation of plas-
minogen to initiate fibrinolysis, enhancing macrophage-
mediated phagocytosis of apoptotic leukocytes, and
enhancing repair of airway epithelial cells [8-10]. The
finding that annexins A1 and A2 are mainly derived
from airway epithelial cells in healthy individuals fur-
thers understanding of how these cells dampen inflam-
mation in the healthy airway and lung. Thus, although
airway epithelial cells are capable of producing pro-
inflammatory mediators and initiating airway host
defenses, the resting airway epithelium appears to main-
tain homeostasis and the non-inflamed state of the healthy
lung. Despite constant inhalation of organic dusts and
bacteria, inflammation in the lung appears to be limited
by secretion of annexins A1 and A2, club cell secretory
protein, odorant binding protein, chitinase-like proteins,
surfactant proteins A and D, lipoxins and resolvins, as well
as epithelial cell surface expression of integrins and
CD200 [19-21]. This concept suggests that dysregulation
of these effects in airway epithelial cells could lead to
tissue damage from the ensuing inflammatory response.
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higher levels of annexins A1 and A2 in BALF had re-
duced prevalence of clinically apparent pneumonia.
In conclusion, annexin A1 immunolabeling was found
to be most prominent in the surface epithelium, goblet
cells and submucosal glands of the large proximal
airways, and was also detected in the epithelium of
distal airways, blood and BALF neutrophils, and large
foamy macrophages in BALF. Annexin A2 immunola-
beling was most abundant in the epithelial cells of the
distal airways and in endothelial cells, with labeling
also detected in alveoli and proximal airways, as well as in
leukocytes and endothelial cells. The pattern and intensity
of expression in the lung parenchyma was similar in calves
with experimentally induced M. haemolytica pneumonia
as in sham-inoculated calves, for both annexin A1 and
A2. These findings imply that annexin A1 in the BALF
of healthy calves mainly originates from the airway
epithelium, whereas annexin A2 in BALF arises from
airway epithelium and mucosal leukocytes. In BALF
from inflamed lung, annexins A1 and A2 may also
originate from leukocytes.Additional files
Additional file 1: Immunohistochemistry for annexin A1 in normal
tissues. (A) Trachea, with intense labeling of surface epithelium and
tracheal glands. (B) Trachea; absence of labeling with the control
antibody against Toxoplasma. (C) Bronchus, with labeling of surface
epithelium including cilia and goblet cells (arrows). Inset: negative
control (pre-incubation of antibody with antigen). (D) Weaker labeling
of bronchiolar epithelium. (E) Bronchiole, negative control (prior
adsorption of primary antibody with annexin protein) with partially
abrogated labeling. (F) Absence of labeling of alveolar septa; minor
labeling of bronchiolar epithelium.
Additional file 2: Immunohistochemistry for annexin A2 in normal
tissues. (A) Trachea, with labeling of surface epithelium, mucosal glands,
and lymphocytes in the lamina propria. Goblet cells or cilia of the respiratory
epithelium were not labeled (arrow). (B) Bronchus, similar labeling as in the
trachea. (C) Bronchus. Absence of labeling in the negative control using
antibody against influenza virus. (D) Trachea, with strong labeling of
leukocytes but weak labeling of epithelium. (E) Bronchus, similar labeling as
in the trachea. (F) Bronchiole, with prominent labeling of the epithelium.
Additional file 3: Immunohistochemistry for annexin A2 in normal
tissues. (A) Trachea, with labeling of tracheal glands. (B) Absence of
labeling of alveolar septa. Blood vessels (arrows) and bronchiolar epithelium
is labeled. (C, D) Labeling of individual cells in the alveolar septa consistent
with macrophages or endothelium. (E) Intense labeling of endothelial cells
in the lamina propria of a bronchus.
Additional file 4: Focal coagulation necrosis and inflammation in
the lung of a calf challenged with M. haemolytica. (A) Focal necrosis
(lower right) separated from more normal lung (upper left) by a dense
band of necrotic leukocytes. Hematoxylin and eosin. (B) Annexin A1
expression in leukocytes in the necrotic lesion and in the band of
leukocytes surrounding it. (C) Negative control for annexin A1 immunostain,
using a primary antibody against Toxoplasma. (D) Scant annexin A2
expression in exudate surrounding the focal area of necrosis. (E) Negative
control for annexin A2 immunostain, using a primary antibody against
influenza virus.
Additional file 5: Immunohistochemistry for annexin A1 and A2 in
the lung of a calf challenged with M. haemolytica. (A) Strong labellingof annexin A1 in necrotic leukocytes bordering an area of necrosis. (B)
Weak labelling of annexin A2 in necrotic leukocytes bordering an area of
necrosis. (C) Inflamed bronchiole, with moderate labeling for annexin A1.
(D) Inflamed bronchiole, with weak labeling for annexin A2. (E) Inflamed
bronchiole. There is annexin A1 labeling of goblet cells including those
that have been shed from the epithelium, but exudate neutrophils are
unlabeled. (F) Inflamed bronchiole. Annexin A2 labeling of bronchiolar
exudate, but not of goblet cells or neutrophils.
Additional file 6: Semi-quantitative scoring of immunohistochemical
labeling of annexins A1 and A2 in the respiratory tract of six calves.
Three calves had been infected with Mannheimia haemolytica by
intrabronchial challenge, and three were unchallenged controls.
Additional file 7: Immunocytochemistry for annexin A1 in normal
blood leukocytes and normal bronchoalveolar lavage fluid (BALF).
(A) Blood smear, Wright’s stain. (B) Neutrophils in blood labeled for
annexin A1; monocytes and lymphocytes are unlabeled. (C) Negative
control, using an antibody against Toxoplasma. (D) Wright’s stain of BALF
leukocytes, showing macrophages and a single neutrophil. (E) BALF;
Annexin A1 labeling in the cytoplasm of large foamy macrophages, but
not in other macrophages. (F) BALF; neutrophils are rare in normal BALF
but those present are labeled for annexin A1.
Additional file 8: Flow cytometry for surface expression of annexin
A1 in normal bovine blood leukocytes. (A) Scatterplot, indicating
forward- and side-scatter characteristics of neutrophils, lymphocytes and
monocytes. (B, C, D) Histograms of fluorescence (annexin A1) vs. cell
count for cells gated as neutrophils (B), lymphocytes (C) and monocytes
(D). Blue: labeled with antibody against annexin A1; red: negative control
(primary antibody omitted). (E) Flow cytometric detection of annexin A1
on the surface of blood leukocytes. Positive: antibody against annexin A1;
negative: omission of the primary antibody. Median ± SEM from 8
animals. The MFI was significantly different from the negative control
for lymphocytes (P < 0.0001) and monocytes (P = 0.0003) but not for
neutrophils (P = 0.366).
Abbreviations
ICC: Immunocytochemistry; IHC: Immunohistochemistry; MFI: Median
fluorescence intensity.
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